Category Archives: Scientific Journal

Mikhail Blagosklonny Career and Achievements

Mikhail Blagosklonny currently serves as the professor of oncology in an institution known as Roswell Park Cancer Institute in the US. Mikhail acquired this position in the year 2009, and he has worked very hard to bring changes in cancer research. Before obtaining this position, Mikhail was serving a senior scientist in an organization referred to as Ordway Research Institute in New York.

Before his appointment as the senior scientist, Mikhail was working as the associate professor of medicine at New York Medical College. His accomplishments in this institution have played a crucial role in his career. Mikhail Blagosklonny is also the chief editor for one of the most respected scientific journals in the world, known as Oncotarget. The successful scientist is an important party in the journal, and he plays a major role in cell death and differentiation department.

Mikhail is also working as an associate editor for cancer therapy and biology in Oncotarget. Apart from these positions, the scientist serves as the chief editor and founder editor for a prominent journal in the medical world known as Cell Cycle. His academic background has played a key role in his success. Read more about Mikhail at LinkedIn

Mikhail Blagosklonny went for his higher education at the well-known First Pavlov State University, located in St Petersburg where he specialized in internal medicine. Later on, he acquired his Ph.D., specializing in cardiology and experimental medicine. His role in aging and cancer research has earned him a lot of respect in the world.

Mikhail is also famed for his advocacy for the use of a cancer drug known as Rapamycin. According to Mikhail, the drug elongates the life of human being. The successful scientist has done a lot of research on cancer therapies and mechanisms of aging. In a recent publication, Mikhail proposes the use of Rapamycin for anti-aging.

Mikhail Blagosklonny has several publications under his name. Reports indicate that the scientist has written over three hundred papers. He has also recorded over twenty-five thousand citations. It is evident that the scientist has transformed the lives of many people who have cancer. He has also assisted many physicians in his career. Visit ResearchGate.Net to learn more about Mikhail’s latest work.

Oncotarget: A Scientific Journal Prepared for the Digital Era

Oncotarget is a multi-disciplinary, public access medical journal. The journal contains countless scholarly articles pertaining to cancer research, and is currently developing sections for articles dealing with other medical subjects such as cardiovascular disease, immunology, and aging. The current editors-in-chief are prominent cancer researchers Dr. Andrei Gudkov and Dr. Mikhail Blagosklonny. According to the Roswell Park Cancer Insitute, Gudkov is a leading cancer researcher on scijournal.org and Chair of the Department of Cell Stress Biology, while Blagosklonny is a professor in oncology, holding both an M.D. and Ph.D. About six years ago, Gudkov and Blogsklonny founded Oncotarget with the shared goal of making scientific research more accessible to the public. They wished to found a website in which scientists can quickly and easily share the results of their research with the scientific community and non-scientists as well, so that the availability of cutting-edge research on Facebook would get more people interested in science and medicine. Other distinguished scientists also serve as editors, such as William G. Kaelin Jr and Gregg Semenza, who, according to the website’s homepage, won the 2016 Lasker Award for the discovery of the oxygen-sensing pathway.  The home page contains news pertaining to any updates the website as well as vouchers for the credibility of the website for new users. For example, the front page proudly displays the Q1 ranking the journal received from Scimago Journal and Country Rankings (Q1 being the highest rank a journal can possibly obtain in the ranking system). The website even boasts a five year impact factor of 5.415, indicating that the publication has been cited over ten thousand times in the past five years. The side bar offers archives for readers on Bioxbio.com to find all published articles, which can be viewed as an HTML, or downloaded as a pdf. There is also a section describing the process of being published by the website for prospective authors, as well as a section featuring interviews of some of the websites most outstanding authors.

Reference: http://endnote.com/downloads/style/oncotarget